Press Releases April 21, 2026 07:18 AM

Northrop Grumman Releases First Quarter 2026 Financial Results

Northrop Grumman announces Q1 2026 earnings and hosts webcast for investor update

By Priya Menon
Share
Twitter Reddit Facebook LinkedIn
NOC

Northrop Grumman Corporation released its financial results for the first quarter of 2026 and scheduled a live webcast of its earnings conference call to provide detailed insights to investors. The company continues to focus on delivering advanced aerospace and defense technology solutions.

Northrop Grumman Releases First Quarter 2026 Financial Results
NOC
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Northrop Grumman reported Q1 2026 financial results as per regulatory filings.
  • The company scheduled a webcast for its earnings call to engage with investors.
  • Northrop Grumman emphasizes its leadership in global aerospace and defense technology sectors.

FALLS CHURCH, Va., April 21, 2026 (GLOBE NEWSWIRE) -- Northrop Grumman Corporation (NYSE: NOC) has released its first quarter 2026 financial results. A copy of the earnings release has been furnished in the company’s Form 8-K filing and is also available on the company's investor relations website at http://investor.northropgrumman.com.

Earnings Call Webcast

As previously announced, Northrop Grumman will webcast its earnings conference call at 9:30 a.m. Eastern time today. A live audio broadcast of the conference call will be available on http://investor.northropgrumman.com.

About Northrop Grumman

Northrop Grumman is a leading global aerospace and defense technology company. Our pioneering solutions equip our customers with the capabilities they need to connect and protect the world, and push the boundaries of human exploration across the universe. Driven by a shared purpose to solve our customers’ toughest problems, our employees define possible every day.

Media Contact

News Bureau
[email protected]

Todd Ernst
[email protected]


Risks

  • Potential market and economic conditions could impact future contract awards and revenues.
  • Dependence on government defense budgets and policies may affect business performance.
  • Technological innovations by competitors could pose challenges to sustaining market leadership.

More from Press Releases

Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026